81 – 90 of 365
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Four-Year Durability of Initial Combination Therapy with Sitagliptin and Metformin in Patients with Type 2 Diabetes in Clinical Practice; COSMIC Study.
(
- Contribution to journal › Article
- 2014
-
Mark
The neuro-incretin concept.
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Insulin plus incretin: A glucose-lowering strategy for type 2-diabetes.
(
- Contribution to journal › Scientific review
-
Mark
Pleiotropic Mechanisms for the Glucose-Lowering Action of DPP-4 Inhibitors.
(
- Contribution to journal › Article
-
Mark
Surrogate measures of insulin sensitivity vs the hyperinsulinaemic-euglycaemic clamp: a meta-analysis
(
- Contribution to journal › Article
-
Mark
Impact of glucose dosing regimens on modeling of glucose tolerance and β-cell function by intravenous glucose tolerance test in diet-induced obese mice.
(
- Contribution to journal › Article
-
Mark
Conditional glucagon receptor overexpression has multi-faceted consequences for beta-cell function.
(
- Contribution to journal › Article
-
Mark
Dipeptidyl peptidase-4 (DPP-4): Localization and activity in human and rodent islets.
(
- Contribution to journal › Article
-
Mark
GLP-1 released to the mesenteric lymph duct in mice: Effects of glucose and fat.
(
- Contribution to journal › Article
-
Mark
Glucagon clearance is regulated by nutritional state : Evidence from experimental studies in mice
(
- Contribution to journal › Article